Spain - Pharmaceuticals

Description

Active substance: tacrolimus (DOE). Quantity of active substance: 0.5 mg, 1 mg, 3 mg and 5 mg. Pharmaceutical form: prolonged-release capsules. Packaging conditions: preferably unit dose.Maximum unit price: EUR 17,73/packaging 30 0,5 mg capsules, EUR 31,26/packaging 30 1 mg capsules, EUR 60,87/packaging 60 1 mg capsules, EUR 91,49/packaging 30 3 mg capsules, EUR 153,69/packaging 30 5 mg capsules.Number of units planned: 300 packages of 30 capsules of 0.5 mg, 2 000 packages of 30 capsules of 1 mg, 500 packages of 60 capsules of 1 mg, 100 packages of 30 capsules of 3 mg, 1 000 packages of 30 capsules of 5 mg.Estimated maximum budget: 261 113,00 EUR (first year of contract). Active ingredient: tacrolimus (DOE) Quantity of active ingredient: 0.75 mg, 1 mg and 4 mg. Pharmaceutical form: extended release tablet. Packaging conditions: preferably unit dose. Maximum unit price: 17.28 EUR/package of 30 tablets of 0.75 mg, 23.04 EUR/package of 30 tablets of 1 mg, 46.08 EUR/package of 60 tablets of 1mg, 92.16 EUR/package of 30 tablets of 4 mg.Number of units planned: 300 packs of 30 tablets of 0.75 mg, 2 000 packs of 30 tablets of 1 mg, 500 packs of 60 tablets of 1 mg, 1 000 packs of 30 tablets of 4 mg.Estimated maximum budget: 166 464,00 EUR (first year of contract). Active substance: tacrolimus (DOE) Quantity of active substance: 5 mg.Pharmaceutical form: ampoule.Packaging conditions: unit dose.Maximum unit price: 185,74 EUR/pack of 10 1 ml ampoules (5 mg/ml) (taxes not included).Number of units planned: 150 packs of 10 1 ml ampoules (5 mg/ml) (first year of contract).Estimated maximum budget: 27 861,00 EUR (first year of contract).

Opportunity closing date

30 April 2019

Value of contract

£1m-5m